Hunt D R, Allison M E, Prentice C R, Blumgart L H
Am J Surg. 1982 Sep;144(3):325-9. doi: 10.1016/0002-9610(82)90011-3.
A prospective study of coagulation disturbances and endotoxemia in 42 patients having major pancreatic or biliary surgery was performed. Endotoxin, soluble fibrin, and fibrin degradation products were measured before and after operation in 28 patients with obstructive jaundice and in 14 nonjaundiced controls. In the control group there was one death and no unexplained fever or postoperative hemorrhage. The jaundiced group had more complications: seven deaths, nine episodes of fever, and six episodes of hemorrhage. Soluble fibrin was detected only in patients with obstructive jaundice, in whom it occurred in 38 percent before operation. Positive endotoxin assay was as common in control patients as in the jaundiced group, but in the latter endotoxin was associated (p less than 0.05) with increased FDP and soluble fibrin. Patients with endotoxin or increased FDP levels before operation for jaundice carry a poor prognosis (7 of 11 died). Preoperative bowel preparation in 16 of the jaundiced patients did not affect the outcome.
对42例接受胰腺或胆道大手术的患者进行了一项关于凝血功能障碍和内毒素血症的前瞻性研究。对28例梗阻性黄疸患者和14例非黄疸对照组患者在手术前后测定了内毒素、可溶性纤维蛋白和纤维蛋白降解产物。对照组有1例死亡,无不明原因发热或术后出血。黄疸组并发症更多:7例死亡、9次发热和6次出血。仅在梗阻性黄疸患者中检测到可溶性纤维蛋白,术前发生率为38%。内毒素检测阳性在对照组患者和黄疸组中同样常见,但在后者中,内毒素与纤维蛋白降解产物增加和可溶性纤维蛋白相关(p<0.05)。术前黄疸患者内毒素或纤维蛋白降解产物水平升高预后较差(11例中有7例死亡)。16例黄疸患者术前肠道准备对结果无影响。